Blog
RSS FeedPosted by Michael Wonder on 19 Jan 2018
Drug maker raises U.S. price of muscular dystrophy treatment
18 January 2018 - Cost of drug Emflaza, which came under scrutiny last year, will go up by 9% for regular ...
Posted by Michael Wonder on 08 Jan 2018
Plans to slash medical costs in America run into generic drug concerns
6 January 2018 - FDA generics push comes amid quality enforcement woes in India. ...
Posted by Michael Wonder on 07 Jan 2018
Humira’s best-selling drug formula: start at a high price. Go higher.
6 January 2018 - Humira is the best-selling prescription drug in the world. You may have seen the commercials. ...
Posted by Michael Wonder on 03 Jan 2018
Gene therapy for inherited blindness sets precedent: 850,000 dollar price tag
3 January 2018 - A landmark gene therapy to treat a rare, inherited form of blindness will cost $850,000 — ...
Posted by Michael Wonder on 03 Jan 2018
Statement from FDA Commissioner on new steps to facilitate efficient generic drug review to enhance competition, promote access and lower drug prices
3 January 2018 - The FDA today announced additional steps to encourage generic competition as part of our continued implementation of ...
Posted by Michael Wonder on 28 Dec 2017
Prices of generic drugs associated with numbers of manufacturers
28 December 2017 - Low-cost generic drugs have improved outcomes in patients while saving the health care system more than $1 ...
Posted by Michael Wonder on 26 Dec 2017
Cancer drug price rises 1,400% with no generic to challenge it
25 December 2017 - Lomustine among 319 drugs with expired patents but no copies; FDA trying to boost competition. ...
Posted by Michael Wonder on 15 Dec 2017
FDA targets insulin for increased competition to lower prices
16 December 2017 - Prices of the diabetes medicine have risen 270%. ...
Posted by Michael Wonder on 05 Dec 2017
This company is about to flood the U.S. with cheap HIV drugs
5 December 2017 - Patents on key branded medicines to start expiring soon. ...
Posted by Michael Wonder on 04 Dec 2017
Alnylam chief makes pricing pledges before drug is even approved
30 November 2017 - For fifteen years, John Maraganore has been the chief executive of Alnylam Pharmaceuticals, working to prove ...
Posted by Michael Wonder on 15 Nov 2017
Trump's HHS secretary nominee boosted drug prices while at Eli Lilly
14 November 2017 - His record suggests he’s unlikely to push pricing policies that would hit pharmaceutical companies’ pocketbooks. ...
Posted by Michael Wonder on 13 Nov 2017
High costs of FDA approval for formerly unapproved marketed drugs
13 November 2017 - In May 2017, the US FDA announced a Drug Competition Action Plan, designed to address competition and ...
Posted by Michael Wonder on 11 Oct 2017
An FDA program to approve old drugs causes higher prices and shortages
11 October 2017 - In 2006, the FDA launched a program to require drug makers to win approval of medicines ...
Posted by Michael Wonder on 11 Oct 2017
Here come more gene therapies -- and more pricing debates
11 October 2017 - Tomorrow an advisory committee to the FDA will meet to discuss Luxturna (voretigene neparvovec), a gene ...
Posted by Michael Wonder on 17 Sep 2017
Cheaper drug trials would lower prices: FDA chief
15 September 2017 - Decreasing the time and cost it takes to develop a drug would lower drug prices, FDA ...